FDA Approved: BENZONATATE — Supplemental Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved a supplemental application for Benzonatate by Bionpharma Inc. (ANDA 081297), resulting in supplemental approval for the generic cough suppressant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cough

Drugs mentioned

• Benzonatate (BENZONATATE)

Snippet

SUPPL AP for BENZONATATE (BENZONATATE)